Abstract:BACKGROUND:Estrogen receptor alpha (ER alpha) is expressed in the majority of breast cancers and promotes estrogen-dependent cancer progression. ER alpha positive breast cancer can be well controlled by ER alpha modulators, such as tamoxifen. However, tamoxifen resistance is commonly observed by altered ER alpha signaling. Thus, further understanding of the molecular mechanisms, which regulates ER alpha signaling, is important to improve breast cancer therapy.METHODS:SMURF1 and ER alpha protein expression levels were measured by western blot, while the ER alpha target genes were measured by real-time PCR. WST-1 assay was used to measure cell viability; the xeno-graft tumor model were used for in vivo study. RNA sequencing was analyzed by Ingenuity Pathway Analysis. Identification of ER alpha signaling was accomplished with luciferase assays, real-time RT-PCR and Western blotting. Protein stability assay and ubiquitin assay was used to detect ER alpha protein degradation. Immuno-precipitation based assays were used to detect the interaction domain between ER alpha and SMURF1. The ubiquitin-based Immuno-precipitation based assays were used to detect the specific ubiquitination manner happened on ER alpha.RESULTS:Here, we identify the E3 ligase SMURF1 facilitates ER alpha signaling. We show that depletion SMURF1 decreases ER alpha positive cell proliferation in vitro and in vivo. SMURF1 depletion based RNA-sequence data shows SMURF1 is necessary for ER alpha target gene expression in the transcriptomic scale. Immunoprecipitation indicates that SMURF1 associates with the N-terminal of ER alpha in the cytoplasm via its HECT domain. SMURF1 increases ER alpha stability, possibly by inhibiting K48-specific poly-ubiquitination process on ER alpha protein. Interestingly, SMURF1 expression could be induced via estradiol treatment.CONCLUSIONS:Our study reveals a novel positive feedback between SMURF1 and ER alpha signaling in supporting breast cancer growth. Targeting SMURF1 could be one promising strategy for ER alpha positive breast cancer treatment.

SMURF1 Attenuates Endoplasmic Reticulum Stress by Promoting the Degradation of KEAP1 to Activate NRF2 Antioxidant Pathway

SMURF1, a Promoter of Tumor Cell Progression?

SMURF1 Facilitates Estrogen Receptor Ɑ Signaling in Breast Cancer Cells

Oncogenic Smurf1 promotes PTEN wild-type glioblastoma growth by mediating PTEN ubiquitylation

The Ubiquitination Ligase SMURF2 Reduces Aerobic Glycolysis and Colorectal Cancer Cell Proliferation by Promoting ChREBP Ubiquitination and Degradation.

Overexpressed Smurf1 is degraded in glioblastoma cells through autophagy in a p62-dependent manner

Smurf1 silencing restores PTEN expression that ameliorates progression of human glioblastoma and sensitizes tumor cells to mTORC1/C2 inhibitor Torin1

Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis

Smurf1 polyubiquitinates on K285/K282 of the kinases Mst1/2 to attenuate their tumor-suppressor functions.

Smurf1 Polyubiquitinates on K285/K282 of the Kinases Mst1/2 to Attenuate Their Tumor-Suppressor Functions

AAMP Promotes Colorectal Cancer Metastasis by Suppressing SMURF2-mediated Ubiquitination and Degradation of RhoA

Suppression of the Smurf1 Expression Inhibits Tumor Progression in Gliomas

Targeting Smurf1 to block PDK1-Akt signaling in KRAS-mutated colorectal cancer

KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated β-TrCP1 degradation.

SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation

SMURF1 controls the PPP3/calcineurin complex and TFEB at a regulatory node for lysosomal biogenesis

Targeting the SMURF2-HIF1α axis: a new frontier in cancer therapy

circRNA-SMO upregulates CEP85 to promote proliferation and migration of glioblastoma via sponging miR-326

E3 ubiquitin ligase SMURF2 prevents colorectal cancer by reducing the stability of the YY1 protein and inhibiting the SENP1/c-myc axis

Endoplasmic Reticulum Stress Contributes to Gefitinib-Induced Apoptosis in Glioma

SMURF2 prevents detrimental changes to chromatin, protecting human dermal fibroblasts from chromosomal instability and tumorigenesis